34 min listen
The FDA's Progressive Appeal ft. Allan Shaw
ratings:
Length:
38 minutes
Released:
Feb 15, 2021
Format:
Podcast episode
Description
Allan Shaw rejoins the Business of Biotech with candid and deep commentary on the unprecedented pace of biopharma innovation, and how the FDA is doing in its equally unprecedented effort to keep pace. In particular, Shaw shares his take on the advance of cell and gene therapies, his observation on the outsized approval rate for orphan disease and oncology therapies, and much, much more. *Editor's note: the review of Biogen's Aducanumab, referenced here as taking place in the March timeframe, was extended shortly after this episode was recorded.
Released:
Feb 15, 2021
Format:
Podcast episode
Titles in the series (100)
006: Leaving The Incubator With Kavitha Iyer Rodrigues by Business Of Biotech